Ascentage Pharma Group International (HKG:6855) appointed Faiçal Miyara as chief business officer and Jim Ziegler as chief commercial officer.
Miyara will oversee the company's global business development, while Ziegler will lead commercialization of its products in the United States and other markets outside China, according to a Monday Hong Kong bourse filing.